AlphaYouRL
Insider selling
Ryan Lynch sold $4K of Crescent Biopharma, Inc. (CBIO) stock
Ryan Lynch sold 240 shares of CBIO stock worth $4K, per an SEC Form 4 filed Sep 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 16, 2026, 2 days before it was made public.
CBIO has moved -4.3% since the trade date, from $17.18 to $16.44 (Sep 22, 2026 close).
- Traded
- Sep 16, 2026
- Disclosed
- Sep 18, 2026
- Filing delay
- 2 days
- Price since
- -4.3%
- Source
- SEC Form 4
More CBIO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.